Notice2026-04970
Importer of Controlled Substances Application: Purisys, LLC
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 13, 2026
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 49 (Friday, March 13, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 49 (Friday, March 13, 2026)]
[Notices]
[Page 12446]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-04970]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1677]
Importer of Controlled Substances Application: Purisys, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Purisys, LLC has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 13, 2026. Such persons may also file a written request for a
hearing on the application on or before April 13, 2026.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 4, 2026, Purisys, LLC, 1550 Olympic Drive,
Athens, Georgia 30601-1602, applied to be registered as an importer of
the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
Nabilone................................ 7379 II
Phenylacetone........................... 8501 II
Ecgonine................................ 9180 II
Levorphanol............................. 9220 II
Methadone............................... 9250 II
Thebaine................................ 9333 II
Opium, Raw.............................. 9600 II
Opium, Powdered......................... 9639 II
Opium, Granulated....................... 9640 II
Noroxymorphone.......................... 9668 II
Poppy Straw, Concentrate................ 9670 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to import Opium, Raw (9600), Opium, Powered
(9639), and Opium, Granulated (9640) to manufacture an Active
Pharmaceutical Ingredient (API) only for distribution to its customers.
The company plans to import Phenylacetone (8501), and Poppy Straw
Concentrate (9670), to bulk manufacture other controlled substances for
distribution to its customers. The company plans to import impurities
of buprenorphine that have been determined by DEA to be captured under
Thebaine (9333). In reference to Marihuana Extract (7350), Marihuana
(7360), and Tetrahydrocannabinols (7370), the company plans to import
as synthetic. The company plans to import an isomer of Methadone (9250)
which is not currently available domestically to manufacture a non-
controlled substance. No other activities for these drug codes are
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Thomas Prevoznik,
Deputy Assistant Administrator.
[FR Doc. 2026-04970 Filed 3-12-26; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on March 13, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.